| ANTIBODY | CLONE | FLOW/IHC | DESCRIPTION |
| A-ACT | A1A88 | IHC | Alpha-1-antichymotrypsin, myeloid cells, histiocytes |
| AAT | Polyclonal | IHC | Alpha-1-antitrypsin; hepatocellular cells |
| ACTH | Polyclonal | IHC | Human Adrenocorticotropic Hormone, pituitary |
| Actin | HHF-35 | IHC | Muscle, myofibroblastic and myeloepithelial cells |
| AE1/AE3 | AE1&AE3 | IHC | Pankeratin cocktail; low and high molecular weights |
| AFP | Polyclonal | | Alpha Fetoprotein; hepatocellular and germ cell tumors |
| ALK-1 | ALK1 | IHC | Anaplastic Large Cell Lymphoma |
| Amyloid A | mc1 | IHC | Reactive systemic (secondary) amyloidosis |
| Annexin-1 | 29 | IHC | Hairy Cell Leukemia marker |
| BCA-225 | CU18 | IHC | Breast carcinomas, other carcinomas |
| BCL-1/Cyclin | D1 DCS-6 | IHC | Cyclin D1/PRAD1, mantle cell lymphoma |
| BCL-2 | 124 | IHC | B-cell subset, follicular lymphoma |
| BCL-2 | 124 | Flow | B-cell subset, over expressed in follicular lymphoma |
| BCL-6 | PG-B6p | IHC | Follicle center B-cells |
| BerEP4 | BerEP4 | IHC | Epithelial antigen, adenocarcinoma subset |
| Beta-Catenin | Beta-Catenin-1 | IHC | Colon, breast, other GI tumors |
| BF-1 | 8A3 | IHC | T-cell receptor beta F1 |
| BOB-1 | Polyclonal | IHC | B-cell transcription factor |
| CA125 | OC125 | IHC | Ovarian, breast, others |
| CA15.3 | DF3 | | Adenocarcinoma, subset |
| CA19.9 | 116-NS-19-9 | IHC | GI, ovary, lung tumors |
| Calcitonin | Polyclonal | IHC | Thyroid, medullary carcinoma |
| Caldesmon | h-CD | IHC | Smooth muscle and non-muscle contraction |
| Calponin | CALP | IHC | Myoepithelial and myofibroblastic cells |
| Calretinin | Polyclonal | IHC | Mesothelial cells |
| CAM 5.2 | CAM 5.2 | IHC | Low molecular weight keratins |
| Cathepsin D | Polyclonal | IHC | Cathepsin D, breast carcinoma |
| CD10 | 56C6 | IHC | Follicle center B-cells, endometrial stromal and myoepithelial cells, CALLA |
| CD10 | HI10a | Flow | Follicle center B-cells, CALLA, myeloid subset |
| CD103 | Ber-ACT8 | Flow | Activated cells, hairy cell leukemia |
| CD117 | Polyclonal | IHC | c-kit ligand, myeloid and mast cell marker, GIST |
| CD117 | 104D2 | Flow | Stem cell receptor (c-kit), myeloid cells |
| CD11b | D12 | Flow | Monocytes/macrophages, dendritic, granulocytes, NK cells, myeloid differentiation |
| CD11c | S-HCL-3 | Flow | Monocytes, myeloid subset, hairy cell leukemia |
| CD123 | 9F5 | Flow | Dentritic cell marker |
| CD13 | L138 | Flow | Myeloid cells, monocytes |
| CD138 | MI15 | IHC | Plasma cells and epithelial cell subset |
| CD138 | MI15 | Flow | Plasma cells |
| CD14 | MO-P9 | Flow | Mature monocytes |
| CD15 | MMA | IHC | Epithelial, myeloid and Reed-Sternberg cells |
| CD15 | MMA | Flow | Neutrophils and eosinophils |
| CD16 | NKP15 | Flow | Granulocytes, NK cells |
| CD19 | 4G7, SJ25C1 | Flow | Pan B-cells |
| CD1a | MTB1 | IHC | Cortical thymocytes |
| CD1a | SK9 | Flow | Cortical thymocytes |
| CD2 | AB75 | IHC | Thymic and peripheral T-cells, NK cells |
| CD2 | S5.2 | Flow | Thymic and peripheral T-cells, NK cells |
| CD20 | L26 | IHC | Pan B-cell antigen |
| CD20 | L27 | Flow | Pan B-cells |
| CD21 | 1F-8 | IHC | Follicular dendritic cells, C3d Receptor, B-cell subset |
| CD22 | S-HCL-1 | Flow | Pan B-cells |
| CD23 | MHM6 | IHC | B-cell subset, CLL/SLL, follicular dendritic meshwork |
| CD23 | 1B12 | Flow | Mature B-cells, CLL |
| CD25 | TAL.1B5 | IHC | TAC, Activated T and B-cells, hairy cell leukemia |
| CD25 | 2A3 | Flow | Activated T and B-cells, hairy cell leukemia |
| CD3 | Polyclonal | IHC | Pan T-cells |
| CD3 | SK7 | Flow | Pan T-cells |
| CD30 | Ber-H2 | IHC | Activation Antigen; Reed-Sternberg cells, ALCL (Ki-1) |
| CD30 | Ber-H2 | Flow | Activation antigen; Reed-Sternberg cells |
| CD31 | JC/70A | IHC | Endothelial cells |
| CD33 | P67.6 | Flow | Myeloid cells, monocytes |
| CD34 | QBEnd 10 | IHC | Endothelial and stem cells, GIST, Blasts |
| CD34 | 8G12 | Flow | Precursor cells |
| CD35 | RLB25 | IHC | Follicular Dendritic Cells |
| CD38 | HB-7 | Flow | Activated T, B, myeloid cells, B-cell subset |
| CD4 | IF6 | IHC | Helper T-cells, thymocyte subset, monocytes |
| CD4 | SK3 | Flow | Helper T-cells, thymocyte subset, monocytes |
| CD41a | H1p8 | Flow | Fibrinogen receptor, von Willebrand factor (vWf), platelets and megakaryocytes |
| CD43 | DF-T1 | IHC | T-cells, myeloid cells, B-cell subset |
| CD43 | 1G10 | Flow | T-cells, myeloid cells, B-cell subset |
| CD45 | RP2/18 | IHC | Leukocyte common antigen |
| CD45 | 2D1 | Flow | Leukocyte common antigen |
| CD45RA | 4KB5 | IHC | Pan B-cell antigen (4KB5) |
| CD45RA | L48 | Flow | Resting/naive T-cells |
| CD45RO | UCHL1 | IHC | T-cells, macrophages, granulocytic precursors |
| CD45RO | UCHL-1 | Flow | Activated/memory T-cells |
| CD5 | 4C7 | IHC | Pan T-cells, B-cell subset thymic carcinoma |
| CD5 | L17F12 | Flow | Pan T-cells, mature B-cell subset (B1a cells) |
| CD52 | MCA1642F | Flow | Lymphocytes, monocytes, Campath® antigen |
| CD55 | N-L063 | Flow | Decay Accelerating Factor, Leukocytes, Erythrocytes, PNH |
| CD56 | 123C3.D5 | IHC | N-CAM; neuroendocrine marker, NK cells |
| CD56/NCAM | MY31 | Flow | T-cell subset, NK cells |
| CD57 | NK1 | IHC | Neuroendocrine marker, NK cells |
| CD57 | HNK-1 | Flow | T-cell subset, NK cells |
| CD59 | MEM-43 | Flow | Reactive Lysis Inhibitor, Leukocytes, Erythrocytes, PNH |
| CD61 | Y2/51 | IHC | Megakaryocytes and platelets |
| CD61 | ____ | Flow | Megakaryocytes, platelets |
| CD64 | MD22 | Flow | Monocytes, myeloid subset |
| CD68 | KP1 | IHC | Macrophages, monocytes |
| CD7 | CD7-272 | IHC | Pan T-cells, NK cells |
| CD7 | 4H9 | Flow | Thymic and peripheral T-cells, NK cells |
| CD71 | L01.1 | Flow | Transferrin receptor |
| CD79a | 1.10E+04 | IHC | B-cells, plasma cells |
| CD79a | HM47 | Flow | B-cells, plasma cells |
| CD8 | 1A5 | IHC | Suppressor/cytotoxic T-cells; splenic littoral cells |
| CD8 | SK1 | Flow | Suppressor T-cells, NK cells, thymocyte subset |
| CD99 | 1.20E+08 | IHC | PNET, Ewing’s sarcoma |
| CDX2 | CDX2-88 | IHC | Carcinoma subset; intestinal-type tumors |
| CEA monoclonal | II-7 | IHC | Carcinoembryonic antigen, adenocarcinoma |
| CEA polyclonal | Polyclonal | IHC | Carcinoembryonic antigen, adenocarcinoma |
| Chromogranin A | DAK-A3 | IHC | Neuroendocrine markers |
| cIgA | 14-3-26 | Flow | Immunoglobulin A heavy chain |
| cIgG | C3-124 | Flow | Immunoglobulin G heavy chain |
| cIgM | 145-8 | Flow | Immunoglobulin M heavy chain |
| CK14 | LL002 | IHC | Squamous epithelia, renal oncolytic tumors, metaplastic breast carcinoma |
| CK17 | E3 | IHC | Carcinoma subset (including pancreaticobiliary) |
| CK19 | RCK 108 | IHC | Carcinoma subset (including pancreatobilary); 46 kD keratin |
| CK20 | Ks 20.8 | IHC | Carcinoma subset (GI, others); 46 kD keratin |
| CK5/6 | D5/16 B4 | IHC | Squamous and mesothelial cells |
| CK7 | K72 | IHC | Carcinoma subset |
| CK8 | 35ßH11 | IHC | LMW cytokeratin, non-squamous cell tumors |
| CK903 | 34ßE12 | IHC | High molecular weight cytokeratin |
| cKappa | TB28-2 | Flow | Kappa Ig light chain, B-cells, plasma cells |
| cLambda | 1-155-2 | Flow | Lambda Ig light chain, B-cells, plasma cells |
| CMV | DDG9/CCH2 | IHC | Cytomegalovirus |
| Collagen IV | CIV22 | IHC | Type IV collagen, basement membrane protein |
| COX-2 | SP-21 | IHC | Cyclooxygenase enzyme, upregulated in many tumors |
| Cytokeratin | MNF-116 | Flow | Carcinoma subset |
| Desmin | D33 | IHC | Striated and smooth muscle cells |
| E-Cadherin | NCH-38 | IHC | Epithelial cells; ductal-type breast carcinoma |
| EBER | ISH Probe | IHC | EBV early RNA transcript |
| EBV (LMP-1) | CS 1-4 | IHC | Epstein-Barr virus LMP (latent membrane protein) |
| EGFR | 2-18C9 | IHC | Epidermal growth factor receptor |
| EMA | E29 | IHC | Epithelial membrane antigen |
| ER | 1D5 | IHC | Estrogen receptor |
| Factor VIII | Polyclonal | IHC | Von Willebrand receptor; megakaryocytes and endothelium |
| Factor XIIIa | AC-1A1 | IHC | Fibrohistiocytic and dermal dendritic cells |
| Fascin | 55K-2 | IHC | Classical Hodgkin lymphoma, Dendritic meshwork |
| Ferritin | Polyclonal | IHC | Diagnosis of iron deficiency anemia and iron overload |
| FMC7 | FMC7 | Flow | Distinguish typical B-cell CLL from other B-cell non-Hodgkin lymphomas |
| FSH | Polyclonal | IHC | Follicle Stimulating Hormone, Pituitary |
| Gastrin | Polyclonal | IHC | Carcinoid and islet cell tumors |
| GCDFP-15 | 23A3 | IHC | Gross cystic disease fluid protein, breast tumors, others |
| GFAP | Polyclonal | IHC | Glial fibrillary acidic protein |
| Glucagon | Polyclonal | IHC | Islet cell tumor |
| Glycophorin-A | JC159 | IHC | Erythroid cells |
| Glycophorin-A | GAR-2(HIR-2) | Flow | Erythroid cells |
| Granzyme B | Gr B-7 | IHC | Cytotoxic T-lymphocytes and NK cells |
| H. Pylori | Polyclonal | IHC | Distinguish H. Pylori from other types of curved bacteria |
| HAM-56 | HAM-56 | IHC | Macrophages, histiocytes |
| HBcAg | Polyclonal | IHC | Hepatitis B core antigen |
| HBME-1 | HBME-1 | IHC | Mesothelial cells, adenocarcinoma subset |
| HBsAg | 3.00E+07 | IHC | Hepatitis B surface antigen |
| HCG | Polyclonal | IHC | Human chorionic gonadotropin; germ cell tumors |
| HCL | DBA.44 | IHC | Hairy cell leukemia, other B-cells (marginal zone) |
| Hemoglobin | Polyclonal | IHC | Human hemoglobins A, A2, F |
| Hepatocyte | OCH1E5 | IHC | Specific for normal and neoplastic hepatocytes |
| Her2neu/c-erb-2 | Polyclonal | IHC | c-erb-2 oncoprotein |
| HHV8 | 13B10 | IHC | Human herpesvirus 8, Kaposi’s sarcoma, primary effusion lymphoma |
| HLA-DR | L243 | IHC | B-cells, activated T-cells, monocytes |
| HLA-DR | DK22 | Flow | MHC Class II Ag, B-cells, activated T-cells, monocytes |
| HMB45 | HMB45 | IHC | Melanoma-associated marker; angiomyolipomas |
| HPAP | Polyclonal | IHC | Human prostatic acid phosphatase |
| HPL | Polyclonal | IHC | Human placental lactogen |
| HSV | Polyclonal | IHC | Herpes simplex virus |
| IgA | Polyclonal | IHC | Immunoglobulin A heavy chain |
| IgD | Polyclonal | IHC | Immunoglobulin D heavy chain |
| IgG | Polyclonal | IHC | Immunoglobulin G heavy chain |
| IgM | Polyclonal | IHC | Immunoglobulin M heavy chain |
| Inhibin | R1 | IHC | Adrenal cortical and sex cord stromal tumors |
| Insulin | HB125 | IHC | Islet Cell Tumor |
| Kappa | Polyclonal | IHC | Immunoglobulin light chain kappa |
| Ki-67 | Ki-S5 | IHC | Proliferation marker |
| Lambda | Polyclonal | IHC | Immoglobulin light chain lambda |
| Laminin | 4C7 | IHC | Basement membrane laminin |
| Lewis Y | F3 | IHC | Blood group related antigen |
| LH | Polyclonal | IHC | Luteinizing hormone, pituitary |
| Mammaglobin | 304-1A5 | IHC | Breast terminal duct and lobular epithelium |
| Mast Cell Tryptase | AA1 | IHC | Mast cells |
| Melan A | A103 | IHC | Melanoma-associated marker, adrenocortical tumors |
| Mesothelin | 5B2 | IHC | Mesotheliomas, non-mucinous ovarian and squamous tumors of esophagus and cervix |
| MOC-31 | MOC-31 | IHC | Epithelial cells; adenocarcinoma subset |
| MUM-1 | MUM1p | IHC | Late stage B-cells, plasma cells, activated T-cells |
| Muramidase | Polyclonal | IHC | Lysozyme, monocytic cells |
| Myeloperoxidase | Polyclonal | IHC | Myeloperoxidase |
| MyoD1 | 5.8A | IHC | Muscle marker, positive in rhabdomyosarcoma |
| Myogenin | F5D | IHC | Muscle marker, positive in rhabdomyosarcoma |
| NF | 2F11 | IHC | Neurofilament |
| NSE | BBS/NC/VI-H14 | IHC | Neuron-specific enolase |
| Oct-2 | Polyclonal | | B-cell transcription factor |
| Oct-3/4 | SEMGC | IHC | Germ cell tumors |
| p16 | E6H4 | IHC | Cyclin-dependent kinase inhibitor; CIN/high grade SIL |
| P504S | 13H4 | IHC | Prostatic carcinoma and high grade PIN |
| p53 | DO-7 | IHC | Tumor suppressor gene mutation |
| p57 | 57P06 | IHC | Inhibitor of G1 cyclin complex/negative regulator of cell proliferation |
| p63 | 4A4 | IHC | Prostatic basal cells, breast myoepithelial cell |
| Parvovirus B19 | R92F6 | IHC | Parvovirus B19 |
| PAX-2 | Z-RX2 | IHC | Renal cell carcinoma subsets, Wilm's tumor |
| PAX5 | 24 | IHC | Expressed primarily in pro-, pre-, and mature B-cells and Hodgkin cells |
| PLAP | 8A9 | IHC | Placental alkaline phosphatase; germ cell tumors and adenocarcinoma subset |
| Podoplanin | D2-40 | IHC | Lymphatic endothelium |
| PR | PgR 636 | IHC | Progesterone receptor |
| Prolactin | Polyclonal | IHC | Pituitary hormone |
| PSA | ER-PR8 | IHC | Prostate specific antigen |
| PSAP/HPAP | Polyclonal | IHC | Human prostatic acid phosphatase |
| PTH | OP-4 | IHC | Parathyroid hormone |
| Renal cell | 66.4.C2 | IHC | Renal epithelial cell origin |
| S100 | Polyclonal | IHC | Neural crest derivatives |
| sIgM | Polyclonal | Flow | Immunoglobulin M heavy chain |
| sKappa | Polyclonal | Flow | Surface Kappa Ig light chain |
| sLambda | Polyclonal | Flow | Surface lambda Ig light chain |
| SMA | 1A4 | IHC | Smooth muscle actin, myoepithelial and myofibroblastic cells |
| SMHC | SMMS-1 | IHC | Smooth-muscle myosin heavy-chain |
| Somatostatin | Polyclonal | IHC | Islet cell tumors |
| Spirochete | Polyclonal | IHC | Treponema Pallidum (syphilis) |
| Surfactant | PE-10 | IHC | Lung non-small cell carcinomas |
| Synaptophysin | SY 38 | IHC | Neural and endocrine tissues |
| TAG-72 | B72.3 | IHC | Simple Epithelium, Adenocarcinoma |
| TCL-1 | Polyclonal | IHC | T-cell prolymphocytic marker |
| TCRab | WT31 | Flow | T-cell receptor heterodimer complex, major T-cell subset |
| TCRgd | 11F2 | Flow | T-cell receptor heterodimer complex, major T-cell subset |
| TdT | Polyclonal | IHC | Terminal deoxynucleotidyl transferase, precursor B-cells and thymocytes |
| TdT | E17-1519 | Flow | Cortical thymocytes, precursor B-cells |
| Thrombomodulin | 1009 | IHC | Mesothelioma, some epithelial tumors |
| Thyroglobulin | DAK-Tg6 | IHC | Thyroglobulin |
| TIA-1 | TIA-1 | IHC | Stress granules, cytotoxic granules of resting & activated T-cells |
| TRAP | 2.60E+06 | IHC | Tartrate Resistant Acid Phosphatase |
| Tryptase | AA1 | IHC | Mast cell tryptase, mast cells |
| TSH | 42 | IHC | Thyroid stimulating hormone, subset of pituitary tumors |
| TTF1 | 8G7G3/1 | IHC | Thyroid Transcription Factor-1; thyroid and lung tumors |
| Tyrosinase | T311 | IHC | Melanoma |
| Uroplakin | AU1 | IHC | Urothelial carcinoma |
| Vasopressin | Polyclonal | IHC | Vasopressin, Antidiuretic hormone |
| Villin | CWWB1 | IHC | Gastrointestinal mucosal epithelium brush border |
| Vimentin | V9 | IHC | Cytoplasmic intermediate filament; mesenchymal cells and some epithelial tumors |
| Wilm’s Tumor (WT-1) | 6F-H2 | IHC | Desmoplastic SRCT, methothelioma, Mullerian tumors, Wilm’s tumor |
| ZAP-70 | 2F3.2 | Flow | Prognostic factor in CLL/SLL |
| ZAP-70 | 2F3.2 | Flow | Prognostic factor in CLL/SLL |
